Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health Canada Special Access Program
Recent news which mentions Health Canada Special Access Program
EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy
September 27, 2023
Tags
Psilocybin program
Management
Cannabis
From
Benzinga
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
September 08, 2023
Tickers
OPTHF
Tags
Markets
Financing
Psychedelic/Assisted Therapies
From
Benzinga
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
May 18, 2023
Tags
Markets
PharmAla Biotech
Psychedelic/Assisted Therapies
From
Benzinga
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
March 28, 2023
Tags
News
Benzinga
Markets
From
Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
Tickers
OPTHF
PHRRF
RVVTF
Tags
PHRRF
Benzinga
News
From
Benzinga
In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences
January 11, 2023
Tickers
NUGL
TRUFF
Tags
Psilocybin program
Management
Cannabis
From
Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags
psilocybin therapy
Cannabis
Market News
From
Benzinga
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
September 26, 2022
Tickers
CLABF
Tags
Benzinga
CLABF
Penny Stocks
From
Benzinga
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
September 22, 2022
Tickers
DELCF
NUMIF
Tags
NUMIF
Penny Stocks
Ketamine Wellness Centers
From
Benzinga
Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home
September 19, 2022
Tickers
NUMIF
Tags
Market News
Health Canada Special Access Program
Neurology Centre of Toronto
From
Benzinga
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
August 08, 2022
Tickers
OPTHF
Tags
Thomas Hartle
Cannabis
Health Canada Special Access Program
From
Benzinga
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
June 28, 2022
Tickers
HAVLF
OPTHF
Tags
Benzinga
News
Penny Stocks
From
Benzinga
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
June 16, 2022
Tickers
BRAXF
FLHLF
Tags
Global
General
Apex Labs
From
Benzinga
Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments
June 15, 2022
Tickers
BRAXF
Tags
Markets
BRAXF
Kevin Kratiuk
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today